PROCEPT BioRobotics (NASDAQ:PRCT) Trading Down 4.8% - What's Next?
PROCEPT BioRobotics (NASDAQ:PRCT) shares fell 4.8% after reporting mixed Q2 2026 results with revenue growth but a larger-than-expected loss and continued unprofitability. The company faces a class-action lawsuit regarding alleged misleading statements about demand and inventory, adding to investor uncertainty. Despite a CEO stock …